Vimarsana
Biggest News Aggregation in the World

Page 6 - Fire Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fire Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fire Capital Today - Breaking & Trending Today

Celcuity's (CELC) "Buy" Rating Reaffirmed at Stifel Nicolaus - Vimarsana News

Celcuity's (CELC) "Buy" Rating Reaffirmed at Stifel Nicolaus

Stifel Nicolaus reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $40.00 price objective on the stock. A number of other research firms have also issued reports on CELC. Needham & Company LLC reissued a buy rating and set […]

Kezar Life Sciences, Inc. (NASDAQ:KZR) Short Interest Update - Vimarsana News

Kezar Life Sciences, Inc. (NASDAQ:KZR) Short Interest Update

Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Free Report) saw a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 4,150,000 shares, a growth of 8.6% from the April 15th total of 3,820,000 shares. Based on an average daily volume of 778,300 shares, the days-to-cover […]

Leerink Partnrs Weighs in on Compass Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CMPX) - Vimarsana News

Leerink Partnrs Weighs in on Compass Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CMPX)

Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Compass Therapeutics in a research report issued on Monday, May 13th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of ($0.11) per share for the quarter, up from their prior estimate […]

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest Update - Vimarsana News

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest Update

Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 3,900,000 shares, an increase of 7.4% from the April 15th total of 3,630,000 shares. Based on an average daily volume of 634,900 shares, the days-to-cover ratio […]

Needham & Company LLC Reaffirms "Buy" Rating for TScan Therapeutics (NASDAQ:TCRX) - Vimarsana News

Needham & Company LLC Reaffirms "Buy" Rating for TScan Therapeutics (NASDAQ:TCRX)

Needham & Company LLC reiterated their buy rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a report issued on Monday, MarketBeat Ratings reports. They currently have a $11.00 price target on the stock. TCRX has been the topic of a number of other reports. Wedbush reissued an outperform rating and issued a […]